News

Pleasanton, CA – September 17, 2008 – TRIA Beauty, a leader in light-based therapeutic beauty products, announced TRIA Personal Laser Hair Removal System was named a Beauty Breakthrough at the annual Allure Best of Beauty Awards on Monday September 15th. The award ceremony was held in The Plaza, where Allure presented beauty’s best and breakthrough products with their highly coveted seal of approval.

Parsippany, NJ, July xx, 2008 – Dynova Laboratories has announced the acquisition of SiCap Industries LLC and its innovative line of capsaicin-based products marketed under the Sinus Buster brand. This is the initial acquisition for Dynova Laboratories, a new company with expertise in identifying and building successful OTC brands. Dynova’s objective is to bring to market unique and innovative natural supplements that fulfill important, but as yet unmet, consumer needs. All Dynova product launches will meet the company’s stringent safety and efficacy criteria, which were established to ensure a high level of user satisfaction. Dynova is backed by Aisling Capital, a private equity fund investing in life sciences companies.

MALVERN, PA, Jun 03, 2008 (MARKET WIRE via COMTEX News Network) -- In the news release, "Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture," issued earlier today by Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), please be advised that Marketwire incorrectly replaced the "greater than or equal to" symbol with the phrase "less than or equal to" and the "less than or equal to" symbol with the phrase "greater than or equal to" 12 times throughout the text and the chart of the press release. Marketwire accepts full responsibility for these errors. Complete corrected text follows.

April 1, 2008, Ithaca, NY – Advion BioSystems, a leading supplier of microfluidic devices for the life sciences industry, launches the latest advancements in proteomic research - the Advion RePlay and FloTek systems.

Ithaca, NY, March 12, 2008 - Advion BioSciences, Inc., through its BioSystems subsidiary, announces it has acquired certain assets of its long-standing out-sourced production supplier, Washburn Manufacturing Technologies Inc., located near the company’s headquarters in Ithaca, NY. Under the terms of agreement, Advion BioSystems will absorb nearly the entire manufacturing operation and employees of Washburn Manufacturing into its business effective immediately, including the founder of the production company, Tom Washburn.

PRINCETON, NJ, January 25, 2008 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX) announced today that, in line with its strategy to continue the aggressive commercialization of its internal and acquired dermatological products, Mr. Alfred Altomari, the Chief Operating Officer of the Company, will succeed Dr. Geert Cauwenbergh, Founder and Chief Executive Officer of the Company, on March 31, 2008. Dr. Cauwenbergh will continue to serve on the Board of Directors of the Company. Mr. Altomari will join him on the Board, effective immediately, filling the current vacancy on the Board of Directors. During the coming two months, Mr. Altomari and Dr. Cauwenbergh will work closely together to assure an effective and smooth transition of responsibilities.

RESEARCH TRIANGLE PARK, NC, January 15, 2008 -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today announced the successful completion of the Phase I clinical program for Tyrima™, its lead candidate for the treatment of depression and anxiety. Tyrima is a selective and reversible member of a novel class of drugs known as RIMAs, or reversible inhibitors of monoamine oxidase A. The Phase I program included acute dose, repeat dose and fed-fasted studies. The results of all studies were favorable, showing that Tyrima was safe and well tolerated and exhibited good pharmacokinetic properties.